Source: The Journal of Craniofacial Surgery. Unidade: FOB
Subjects: OSTEONECROSE, MANDÍBULA, FIBRINA, PLAQUETAS SANGUÍNEAS
ABNT
MORAES-DA-SILVA, Aneliza de Fatima et al. Bone morphogenetic protein 2 plus leukocyte and platelet-rich fibrin for the treatment of MRONJ. The Journal of Craniofacial Surgery, v. 34, n. 4, p. e338-e341, 2023Tradução . . Disponível em: https://doi.org/10.1097/SCS.0000000000009059. Acesso em: 06 nov. 2024.APA
Moraes-da-Silva, A. de F., Maluf, G., Rubira-Bullen, I. R. F., & Santos, P. S. da S. (2023). Bone morphogenetic protein 2 plus leukocyte and platelet-rich fibrin for the treatment of MRONJ. The Journal of Craniofacial Surgery, 34( 4), e338-e341. doi:10.1097/SCS.0000000000009059NLM
Moraes-da-Silva A de F, Maluf G, Rubira-Bullen IRF, Santos PS da S. Bone morphogenetic protein 2 plus leukocyte and platelet-rich fibrin for the treatment of MRONJ [Internet]. The Journal of Craniofacial Surgery. 2023 ; 34( 4): e338-e341.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/SCS.0000000000009059Vancouver
Moraes-da-Silva A de F, Maluf G, Rubira-Bullen IRF, Santos PS da S. Bone morphogenetic protein 2 plus leukocyte and platelet-rich fibrin for the treatment of MRONJ [Internet]. The Journal of Craniofacial Surgery. 2023 ; 34( 4): e338-e341.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1097/SCS.0000000000009059